Nerve Transfer After Spinal Cord Injuries

Sponsor
Washington University School of Medicine (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT01714349
Collaborator
United States Department of Defense (U.S. Fed)
20
1
1
124.9
0.2

Study Details

Study Description

Brief Summary

Nerve Transfer surgery can provide improved hand function following cervical spinal cord injuries

Condition or Disease Intervention/Treatment Phase
  • Procedure: Nerve Transfer
N/A

Detailed Description

Current treatment strategies of acute cervical spinal cord injuries remain limited. Treatment options that provide meaningful improvements in patient quality of life and long-term functional independence will provide a significant public health impact.

Specific Aim: Measure the efficacy of nerve transfer surgery in the treatment of patients with complete cervical spinal cord injuries with no hand function. Optimize the efficiency of nerve transfer surgery by evaluating patient outcomes in relation to patient selection and optimal timing the the surgery.

Hypothesis: Peripheral nerve transfers in patients with spinal cord injuries will improve hand function and provide improvement in patient quality of life and functional independence.

Study Design

Study Type:
Interventional
Actual Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Restoring Hand Function Using Nerve Transfers in Persons With Spinal Cord Injury
Study Start Date :
Oct 1, 2012
Anticipated Primary Completion Date :
Feb 10, 2023
Anticipated Study Completion Date :
Mar 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Nerve Transfer

Surgical - Nerve transfers for patients with stable cervical spinal cord injuries

Procedure: Nerve Transfer
A nerve transfer procedure will be individualized to each patient's functional deficit.

Outcome Measures

Primary Outcome Measures

  1. Change in upper motor strength [48 months]

    Patients motor strength will be assessed over 48 months of clinical follow-up with conventional manual motor testing

Secondary Outcome Measures

  1. Change in Disabilities of Arm, Shoulder, and Hand (DASH) scores [48 months]

    The change in DASH scores will be followed over time and assessed pre-operatively, 6,12, 18, 24, 36 and 48 months post-operatively.

  2. Change in Short Form 36 (SF-36) scores [48 months]

    The change in SF-36 scores will be followed over time and assessed pre-operatively, 6, 12, 18, 24. 36 and 48 months post-operatively.

  3. Change in Michigan Hand Questionnaire (MHQ) [48 months]

    The change in MHQ will be followed over time and assessed pre-operatively, 6, 12, 18, 24, 36 and 48 months post-operatively.

Other Outcome Measures

  1. Rates of Intraoperative and Post-operative complications [48 months]

    The number of complications within and after the operation.

  2. Effect of timing on surgical intervention [48 months]

    Assess the effect of timing on primary and secondary outcome measures, early (<12 months) vs. (>12 months)

  3. Rate of reoperation [48 months]

    The rate at which a patient needs to be operated on again.

  4. Hand Function, measured by the Sollerman Hand Function Test [48 months]

    The Sollerman Hand Function Test is performed as part of an overall evaluation and assessment by study team Occupational Therapist pre-operatively, post-operatively, and at 6 months, 12 months, 18 months, and 24 months. 36 months and 48 months

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. 18-65 years of age

  2. Informed Consent Document (ICD) signed by patient

  3. Cervical spinal cord injury resulting in arm & hand functional impairment, with at least preserved elbow function

  4. International Classification of Surgery of the Hand in Tetraplegia (ICSHT) category 0

  • 4
  1. Patients with a stable American Spinal Injury Association (ASIA) grade of A, B, or C, or with a diagnosis of central cord syndrome, showing minimal to no evidence of functional improvement in motor examination after at least 6 months of non-operative therapy post-injury

  2. Appropriate candidate for nerve transfer study

  3. Willing and able to comply with the study protocol

  4. < 48 months from injury

Exclusion Criteria:
  1. Active infection at the operative site or systemic infection

  2. Any return or ongoing clinical recovery of distal motor function within 6 months after injury

  3. Physically or mentally compromised

  4. Currently undergoing long-term steroid therapy

  5. Significant joint contractures and/or limitations in passive range of motion in the arm or hand

  6. Active malignancy

  7. Systemic disease that would affect the patient's welfare or the research study

  8. Pregnant

  9. Immunologically suppressed or immunocompromised

  10. Significant pain or hypersensitivity

  11. Previous or current injury preventing use of tendon transfers to restore upper extremity function

  12. Affective disorder of a degree that would make outcome assessment and study participation difficult

  13. History of brachial plexus injury or systemic neuropathic process

Contacts and Locations

Locations

Site City State Country Postal Code
1 Washington University Saint Louis Missouri United States 63110

Sponsors and Collaborators

  • Washington University School of Medicine
  • United States Department of Defense

Investigators

  • Principal Investigator: Wilson Z Ray, MD, Washington University School of Medicine

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Washington University School of Medicine
ClinicalTrials.gov Identifier:
NCT01714349
Other Study ID Numbers:
  • NTSCI -201208137
First Posted:
Oct 25, 2012
Last Update Posted:
Feb 21, 2022
Last Verified:
Feb 1, 2022
Keywords provided by Washington University School of Medicine
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 21, 2022